%0 Figure %A Sato, Miyuki %A Watanabe, Satoshi %A Tanaka, Hiroshi %A Nozaki, Koichiro %A Arita, Masashi %A Takahashi, Miho %A Shoji, Satoshi %A Ichikawa, Kosuke %A Kondo, Rie %A Aoki, Nobumasa %A Hayashi, Masachika %A Ohshima, Yasuyoshi %A Koya, Toshiyuki %A Ohashi, Riuko %A Ajioka, Yoichi %A Kikuchi, Toshiaki %D 2019 %T Survival curves of EGFR-mutated NSCLC patients treated with nivolumab. %U https://plos.figshare.com/articles/figure/Survival_curves_of_i_EGFR_i_-mutated_NSCLC_patients_treated_with_nivolumab_/7989734 %R 10.1371/journal.pone.0215292.g001 %2 https://plos.figshare.com/ndownloader/files/14880749 %K density %K PD-L 1 expression %K HR %K type EGFR NSCLCs %K nivolumab %K tumor microenvironment %K NSCLC patients %K epidermal growth factor receptor %K non-small-cell lung cancers %K EGFR mutations %K NA %K EGFR-tyrosine kinase inhibitors %K progression-free survival %K CD 4 %K CI %K cell death 1 %K T cells %K Foxp 3 %K biomarker %X

(A) Progression-free survival and (B) overall survival of patients treated with nivolumab.

%I PLOS ONE